Trends in the Incidence of Lung Cancer Hospitalizations in Spain, 2001-2011;Tendencias en la incidencia de hospitalizaciones por cáncer de pulmón en España entre 2001 y 2011

Archivos de Bronconeumologia

Volumn 52, Issue 8, 2016, Pages 411-419

  Palacio Nebreda, M Mar ^a   de Miguel Diez, Javier ^b   Villegas Fernández, Francisco Ramón ^c   Segura Fragoso, Antonio ^d   Rodríguez Calderón, Juan Luis ^a   Martínez Hernández, David ^e  

^a HOSPITAL SAN RAFAEL   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^c HOSPITAL CENTRAL DE LA DEFENSA GÓMEZ ULLA   (Spain)

^d INSTITUTO ARAGONÉS DE CIENCIAS DE LA SALUD   (Spain)

^e UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Epidemiological studies; Hospitalization; Lung cancer

Indexed keywords

AGE DISTRIBUTION; AGED; ARTICLE; CANCER INCIDENCE; CANCER RISK; CHARLSON COMORBIDITY INDEX; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEMOGRAPHY; DIAGNOSTIC PROCEDURE; ECONOMICS; FEMALE; HOSPITALIZATION; HOSPITALIZATION COST; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREVALENCE; RETROSPECTIVE STUDY; SEX DIFFERENCE; SOCIOECONOMICS; SPAIN; TREND STUDY; ADULT; AGE; HOSPITAL READMISSION; LENGTH OF STAY; MIDDLE AGED; SOCIAL STATUS; VERY ELDERLY; FACTUAL DATABASE; HOSPITAL ADMISSION; HOSPITAL COST; HOSPITAL DISCHARGE; INCIDENCE; LUNG TUMOR; RESPIRATORY TRACT EXAMINATION; SEX RATIO; STATISTICS AND NUMERICAL DATA; TRENDS; UTILIZATION;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; DATABASES, FACTUAL; DIAGNOSTIC TECHNIQUES, RESPIRATORY SYSTEM; FEMALE; HOSPITAL COSTS; HOSPITALIZATION; HUMANS; INCIDENCE; LENGTH OF STAY; LUNG NEOPLASMS; MALE; MIDDLE AGED; PATIENT ADMISSION; PATIENT DISCHARGE; RETROSPECTIVE STUDIES; SEX DISTRIBUTION; SPAIN;

EID: 84959928561     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1016/j.arbr.2016.06.019     Document Type: Article

References (19)

1. 1 Bello, B., Fadahun, O., Kielkowski, D., Nelson, G., Trends in lung cancer mortality in South Africa: 1995-2006. BMC Public Health., 11, 2011, 209.
2. 2 Chang, J.S., Chen, L.T., Shan, Y.S., Lin, S.F., Hsiao, S.Y., Tsai, C.R., et al. Comprehensive analysis of the incidence and survival patterns of lung cancer by histologies, including rare subtypes, in the era of molecular medicine and targeted therapy: A nation-wide cancer registry-based study from Taiwan. Medicine (Baltimore), 94, 2015, e969.
3. 3 Galceran J, Ameijide A, Carulla M, et al. Estimaciones de la incidencia y superviviencia del cáncer en España y su situación en Europa. Red Española de Registros de Cáncer (REDECAN) 2014 [consultado 15 Ene 2015]. Disponible en: http://redecan.org/es/page.cfm?id=196&title=estimaciones-de-la-incidencia-y-la-supervivencia-del-cancer-en-espana-y-su-situacion-en-europa.
4. 4 Lanuti, M., Hong, H.J., Ali, S., Stock, C., Temel, J., Mathisen, D., Michaelson, J.S., Observations in lung cancer over multiple decades: An analysis of outcomes and cost at a single high-volume institution. Eur J Cardiothora Surg. 46 (2014), 254–261.
5. 5 Patz, E.F. Jr., Pinsky, P., Gatsonis, C., Sicks, J.R., Kramer, B.S., Tammemagi, M.C., et al. Overdiagnosis in low-dose computed tomography screening for lung cancer. JAMA. 174 (2014), 269–274.
6. 6 Youlden, D.R., Cramb, S.M., Baade, P.D., The International Epidemiology of Lung Cancer: geographical distribution and secular trends. J Thorc Oncol. 3 (2008), 819–831.
7. 7 Siegel, R., Naishadham, D., Jemal, A., Cancer statistics, 2012. CA Cancer J Clin. 62 (2012), 10–29.
8. 8 Egleston, B.L., Meireles, S.I., Flieder, D.B., Clapper, M.L., Population-based trends in lung cancer incidence in women. Semin Oncol. 36 (2009), 506–515.
9. 9 Malvezzi, M., Bosetti, C., Rosso, T., Bertuccio, P., Chatenoud, L., Levi, F., et al. Lung cancer mortality in European men: Trends and predictions. Lung Cancer. 80 (2013), 138–145.
10. 10 Hernández-Hernández, J.R., Moreno de Vega-Herrero, M.B., Iglesias-Heras, M., García-García, R., Hernández-Terciado, F., Celdrán-Gil, J., Lung cancer in Avila province, Spain. Incidence rates, epidemiology of the year 2012 and trends in the last 20 years. Semergen. 41 (2015), 362–369.
11. 11 Jankovic, M., Samarzija, M., Jakopovic, M., Kulis, T., Znaor, A., Trends in lung cancer incidence and mortality in Croatia, 1988-2008. Croat Med. 53 (2012), 93–99.
12. 12 Skaug, K., Eide, G.E., Gulsvik, A., Hospitalisation days in patients with lung cancer in a general population. Respir Med. 103 (2009), 1941–1948.
13. 13 Schneider, W., Oertel, I., Unger, G., Further development of the documentation and analysis of causes of death in connection with the introduction of the 9th Revision of the International Classification of Diseases, Injuries and Causes of Death of the World Health Organization. Z Gesamte Hyg Ihre Grenzgeb. 24 (1978), 802–811.
14. 14 Deyo, R.A., Cherkin, D.C., Ciol, M.A., Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 45 (1992), 613–619.
15. 15 García Gómez, M., Urbanos Garrido, R., Castaneda López, R., López Menduiña, P., Direct health care costs of lung and bladder cancer attributable to work. Spain, 2008. Rev Esp Salud Pública. 86 (2012), 127–138.
16. 16 Hernández Hernández, J.R., Tapias del Pozo, J.A., Moreno Canelo, P., Rodríguez Puebla, A., Paniagua Tejo, S., Sánchez Marcos, J.C., Lung cancer incidence in the province of Avila, Spain in 2002 and decade-long trends. Arch Bronconeumol. 40 (2004), 304–310.
17. 17 Sendra-Gutiérrez, J.M., Palma-Ruiz, M., Martín-Martínez, M.A., Sarria-Santamera, A., Clinical care characteristics and factors associated with in-hospital mortality for lung cancer in Spain. Med Clin (Barc). 133 (2009), 8–16.
18. 18 Demeter, S.J., Jacobs, P., Chmielowiec, C., Logus, W., Hailey, D., Fassbender, K., et al. The cost of lung cancer in Alberta. Can Respir J. 14 (2007), 81–86.
19. 19 Wolstenholme, J.W., Whynes, D.K., The hospital costs of treating lung cancer in the United Kingdom. Br J Cancer. 80 (1999), 215–218.